Live Webinar on Dec 4! Cut Through the AI Noise: A Framework for Canadian Clinicians. Register now
[searchwp_form id="1"]

Loading results ...

GLP-1: Navigating New Agents and Total Metabolic Health with Dr. Sean Wharton

April 30, 2026 | 7:00 PM EST

As the GLP1 therapy landscape shifts in 2026, clinical success is being redefined by more than just numbers on a scale. Join Dr. Sean Wharton for an essential update on the diversification of the GLP-1 market, including the impact of new therapeutic entries on patient access. This session moves beyond weight-centric management to explore the systemic, multi-organ benefits of GLP-1s, providing a blueprint for achieving total metabolic health and long-term quality of life in your patients.

Objectives
  1. Advance the Science of Obesity Management
    Evaluate the latest clinical data on incretin therapies and the biological mechanisms that drive weight regain and obesity.
  2. Navigate the Expanding Therapeutic Landscape
    Analyze the clinical role of new and emerging agents, including the impact of increased market options on patient access and treatment selection.
  3. Redefine Clinical Goals in Obesity Medicine
    Discuss the shift from weight-centric metrics toward holistic outcomes, focusing on metabolic health and long-term quality of life.

Login to Access Registration

Webinar registration is open for existing members. Login to access registration or create your

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.